Mitigation Efforts in Arsenic Exposure With Folic Acid Supplementation
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Dec 12, 2022
Trial Information
Current as of July 12, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Folic acid supplementation effects urinary arsenic excretion. In this project investigators propose to investigate if oral folic acid dietary supplementation can increase urinary arsenic metabolite excretion
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥18 years of age
- • Resident of the superfund site
- • Clinically stable with no significant changes in general health status in the past 4 weeks prior to screening as assessed by the investigator
- • Provide written informed consent
- Exclusion Criteria:
- • Pregnancy
- • Ongoing folic acid nutritional supplementation
- • Methotrexate use
- • Megaloblastic anemia
- • Alcoholic liver disease
- • Malabsorptive syndromes - celiac disease, inflammatory bowel disease
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Patients applied
Trial Officials
Kevin G Dsouza, MD
Principal Investigator
University of Alabama at Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials